EG574081 inhibitors are a class of chemical compounds that target the molecular interactions or signaling pathways involving the compound EG574081, which is often associated with cellular processes like enzyme regulation or signaling cascades. These inhibitors typically interact with their target by binding to specific sites, modulating the activity of proteins or enzymes associated with the EG574081 pathway. The design of these inhibitors often focuses on achieving a high degree of specificity to avoid off-target effects and ensure that the inhibitor acts directly on the molecular mechanism of interest. This specificity is usually achieved through precise modifications of the chemical structure, allowing the inhibitors to fit into their target sites in a "lock-and-key" fashion. The chemical structure of these inhibitors may include various functional groups that contribute to their binding affinity, solubility, and overall pharmacokinetic properties, such as aromatic rings, heterocycles, and hydrophobic moieties.
The study of EG574081 inhibitors extends to understanding their biochemical behavior, such as their binding kinetics, stability, and ability to modulate biological pathways associated with EG574081. These compounds are often evaluated in terms of their potency and selectivity, which are critical for achieving the desired effect on the target pathway while minimizing interactions with other cellular components. Advanced synthetic techniques are employed to develop a wide range of these inhibitors, allowing for the exploration of different molecular frameworks and configurations. Structural-activity relationships (SAR) play a significant role in their development, guiding the optimization of chemical features to enhance the affinity for EG574081. The precise modulation of the pathway or interactions involving EG574081 can be instrumental in research focused on biochemical pathways, cellular processes, and mechanisms of molecular regulation, providing key insights into the functional role of EG574081 in various biological systems.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin has been shown to inhibit NF-κB signaling, which is involved in the regulation of DEFB46 gene expression. This inhibition may lead to reduced DEFB46 expression. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol has been demonstrated to suppress NF-κB activation, thereby potentially downregulating DEFB46 expression mediated by this transcription factor. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin has been reported to inhibit NF-κB activation, which could result in decreased transcriptional activity of the DEFB46 gene. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein can interfere with NF-κB signaling, which regulates DEFB46 expression. Its inhibition of NF-κB activation may lead to decreased DEFB46 gene expression. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG has been shown to inhibit NF-κB activation, which plays a role in regulating DEFB46 expression. This inhibition may lead to reduced DEFB46 levels. | ||||||
Apigenin | 520-36-5 | sc-3529 sc-3529A sc-3529B sc-3529C sc-3529D sc-3529E sc-3529F | 5 mg 100 mg 1 g 5 g 25 g 100 g 1 kg | $33.00 $214.00 $734.00 $1151.00 $2348.00 $3127.00 $5208.00 | 22 | |
Apigenin has been found to inhibit NF-κB activation, which is implicated in the regulation of DEFB46 expression. This inhibition may downregulate DEFB46 levels. | ||||||
Baicalein | 491-67-8 | sc-200494 sc-200494A sc-200494B sc-200494C | 10 mg 100 mg 500 mg 1 g | $32.00 $42.00 $162.00 $292.00 | 12 | |
Baicalein inhibits NF-κB signaling, which modulates DEFB46 gene expression. This inhibition may result in reduced DEFB46 expression. | ||||||
Luteolin | 491-70-3 | sc-203119 sc-203119A sc-203119B sc-203119C sc-203119D | 5 mg 50 mg 500 mg 5 g 500 g | $27.00 $51.00 $101.00 $153.00 $1925.00 | 40 | |
Luteolin has been shown to suppress NF-κB activation, which regulates DEFB46 expression. Its inhibitory effect on NF-κB may lead to decreased DEFB46 levels. | ||||||
Galangin | 548-83-4 | sc-235240 | 25 mg | $133.00 | 5 | |
Galangin inhibits NF-κB activation, a transcription factor involved in DEFB46 gene regulation. Its inhibition of NF-κB may result in decreased DEFB46 expression. | ||||||
Naringenin | 480-41-1 | sc-219338 | 25 g | $245.00 | 11 | |
Naringenin has been reported to inhibit NF-κB signaling, which plays a role in the regulation of DEFB46 expression. This inhibition may decrease DEFB46 gene expression. | ||||||